Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

The outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. Currently, there is no specific viral protein-targeted therapeutics. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein remains unclear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar as other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the β-sheet core. Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.

Abstract licence: CC BY-NC-ND

• Flow Cytometry: The Next Revolution · 2023

• The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics · 2023

• The architecture of the SARS-CoV-2 RNA genome inside virion · 2021

• SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA · 2021

• Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages · 2021

• The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA · 2021

• SARS‐CoV‐2 nucleocapsid protein phase‐separates with RNA and with human hnRNPs · 2020

• Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be · 2020

• Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein · 2020

• Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein · 2020

• Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms · 2020

• Adjuvants for Coronavirus Vaccines · 2020

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.